ABSTRACT A continuous Bayesian model was developed by fitting a fl-function to the frequency distributions of resting ejection fraction, exercise ejection fraction, and change in end-systolic volume during exercise measured by radionuclide angiocardiography in a group of 249 men with coronary artery disease (CAD) and in a group of 56 men without disease. This model, then prospectively applied to 250 men with chest pain, did not increase the overall accuracy of the test but did increase the diagnostic content for individual patients. The diagnostic efficacy of the continuous Bayesian model was compared with previously determined optimal discrete criteria of a positive or negative test. Patients with CAD showed a maximum and mean increase in probability of disease of + 0.58 and +0.11, respectively, by the continuous Bayesian model and +0.14 and +0.05, respectively, by discrete criteria. Men without significant disease showed a maximum and mean decrease in probability of disease of -0.73 and -0.38, respectively, by Bayesian analysis and -0.36 and -0.27, respectively, by optimal discrete criteria. Moreover, all 29 patients who died during a 35 month interval after study had a probability of CAD of 0.95 or greater by the continuous Bayesian model. 
MYOCARDIAL ISCHEMIA induced by exercise impairs ventricular function in patients with coronary artery disease (CAD).' Exercise-induced abnormalities of left ventricular function detected by radionuclide ventriculography have been used to diagnose CAD in patients with chest pain.2 3 Previous studies evaluating radionuclide angiocardiography (RNA) for the diagnosis of CAD have used discrete end points of each left ventricular functional parameter measured to define a positive or negative test result. However, variables describing cardiac function are continuous. A patient with severe exercise-induced left ventricular dysfunction, for example, would appear more likely to have CAD than a patient with only mild exerciseinduced dysfunction. Diamond were considered to be "normal." The prevalence of CAD as a function of age and character of chest pain was determined from this population of 5042 men.
Typical angina was defined as: (1) crushing or squeezing in character, (2) substemal in location (with or without arm or neck radiation), (3) (2) an exercise EF at least 6% less than predicted (expected increase in EF with exercise was defined by sex, age, and rest-to-exercise change in the EDV index'0), (3) an exercise-induced increase of greater than 20 ml in end-systolic volume (AESV), or (4) the appearance or exacerbation of a wall motion abnormality during exercise. These criteria were used as discrete end points to define results of studies by RNA as positive or negative.
For the continuous model, resting EF, exercise EF, and AESV were considered as continuous random variables with a range of zero to one. Means and standard deviations were calculated to define a /3-distribution, /B (n,r), for each of the three variables in the two patient populations. The /3-distribution describes the probability of any given test result by RNA occurring in the specified population: The probability of an individual patient having disease was calculated by applying Bayes' theorem of conditional probability to data obtained by RNA:
P(D) . P(RNA ID) (2) P(D) . P(RNAID) + P(D) P(RNAjD) In this formula, RNA is a given test result, P(DIRNA) is the posttest probability of disease given the test result, P(D) is the prior probability of disease (or prevalence), and P(RNA|D) and P(RNA|D) are the probabilities of the test result in the diseased and normal populations. respectively.
Prospective testing of diagnostic model. The derived model was tested prospectively with a separate population of 250 men with chest pain who underwent cardiac catheterization and RNA between January 1, 1980, and September 15, 1981. For each patient the probability of CAD calculated was compared with probability defined by discrete test criteria. The continuous Bayesian model was validated with the chi-square statistic to compare the average posttest probability of disease in each of three subgroups (less than 0.60, 0.60 to 0.90, and greater than 0.90), with the actual incidence of disease in the subgroup identified by catheterization.
Follow-up after cardiac catheterization. Information on life-death status was available on 412 (90%) of the 456 total patients with significant CAD in both the retrospective and prospective groups studied by RNA an average of 35 months after cardiac catheterization. Death from any cause occurred in 29 patients an average of 15 months after cardiac catheterization. Five men had left main CAD, 15 had triple-vessel CAD, six had double-vessel CAD, and three had single-vessel CAD. The incidence of death was then analyzed as a function of pretest and posttest probability of disease.
Results
Prevalence of CAD related to age and type of chest pain.
In the population of 5042 men, 3422 (68%) had typical angina, 1278 (25%) had atypical angina, and 342 (7%) had nonanginal chest pain. There was a sufficient number of patients with typical angina to permit separation into five groups according to age. The number of patients with atypical angina and nonanginal chest pain, however, was adequate to provide data for only four age subgroups in each category of pain. In each pain classification, the fraction of patients in each subgroup of age was plotted at the average age for the subgroup (figure 1). A linear fit to these data gave correlation Validation of model. Posttest probabilities of disease were calculated in the prospective study with the continuous Bayesian model for the 250 patients who underwent both coronary arteriography and RNA after January 1, 1980. Catheterization showed that 207 men had significant CAD. This group comprised 52 patients with single-vessel stenosis, 63 with double-vessel stenosis, 83 with triple-vessel stenosis, and nine with left main coronary artery stenosis. The group of 43 men without significant CAD consisted of 28 with normal coronary arteries and 15 with coronary lesions less than 75%. For each patient, prior probability of CAD was calculated from equation 3, 4, or 5, and the posttest probability of disease after RNA was calculated from equation 6.
In this group of 250 men, individual posttest probabilities of CAD provided by the continuous Bayesian 
.00 In the population of 207 men with significant CAD, application of optimal discrete radionuclide angiocardiographic criteria resulted in 184 of 207 (88.9%) for whom probability of disease correctly increased (table  3) . The continuous Bayesian model yielded an appropriate probability increase for 149 of these 207 patients (72%) (figure 4). Maximum and mean increase in probability were +0.14 and + 0.05 by optimal dis-68 crete criteria and + 0.58 and + 0. 1 1 by the continuous Bayesian model.
The net diagnostic gain for each approach can be determined from the magnitude and number of correct and incorrect changes in probability (table 3). In the 43 men with normal coronary arteries and insignificant CAD, the average diagnostic gain was 0.09 for the discrete model and 0.28 for the continuous Bayesian model. In the 207 men with CAD, the net diagnostic gain was 0.02 for the discrete model and 0.01 for the continuous model. Therefore, for the entire population of 250 patients, the continuous Bayesian model resulted in an average 0.02 more correct change in probability of disease than did the discrete test end points. This slight diagnostic advantage resulted from the greater decrease in probability of disease with the continuous model in patients without CAD. Fifty-eight patients exhibited a large increase in diagnostic gain by use of the continuous model vs 15 patients by use of the discrete model.
Decreases in probability resulting from the continuous Bayesian model occurred more frequently in the group of patients with anatomically less extensive CAD. None of the men with left main CAD showed lower probability of disease; whereas for 18%, 33%, and 46% of patients with triple-, double-, and singlevessel disease, respectively, the probability of CAD was lower. However, the continuous model of data obtained by RNA provided additional diagnostic information for individual patients. In the prospective analysis, the continuous Bayesian approach showed a greater decrease in probability of disease for patients with no significant CAD but a lesser increase in probability of disease for patients with significant CAD. The observation that in both approaches the probability of disease increased little for men with CAD reflects the fact that most patients with CAD had a high probability of disease before values were determined.
Calculation of posttest probabilities of disease by continuous Bayesian analysis may aid in making clinical decisions about individual patients. For example, from our prospective study of 250 men, the criterion that no patient who has a posttest probability equal to or less than 0. 10 be sent for cardiac catheterization would miss one of the 207 patients in our study with significant CAD but would spare 12 of the remaining 43 men (28%) with normal coronary arteries or insignificant disease the risk and discomfort of the procedure.
Of the group of 207 studied, the 29 patients who died at an average of 15 months after initial study all had a posttest probability of disease equal to or greater than 0.95 by the continuous Bayesian model. When age and character of pain are used to define probability of disease, only 12 of these 29 had a probability of disease equal to or greater than 0.95. The fact that prognostic information is added by resting and exercise EF and AESV in this population suggests that the same parameters that detect the presence of CAD also index the severity of disease. Moreover, the fact that no patient died who had a posttest probability of disease less than 0.95 diminishes the clinical importance of an incorrect decrease in probability of disease for men with CAD. If further experience confirms these observations, the most important use of RNA will be to obtain prognostic rather than diagnostic information.
